ANSI/PDA Standard on Cryopreservation of Cells for Cell and Gene Therapies Receives Complete Recognition Status by U.S. FDA CBER

The 2021 standard is included in a cohort of standards relevant to regenerative medicine therapies recognized either completely or partially by the Center for Biologics in 2023. BETHESDA, Md., March 25, 2024 /PRNewswire-PRWeb/ -- PDA today proudly announced at its 2024 Annual Meeting in...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news